Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression data from endometrial cancer patient-derived cells (EDC-PDCs) treated with Efp siRNA

ABSTRACT: To examine the role of Efp in endometrial cancer, patient-derived cells were treated with siRNA targeting Efp (siEfp) or control siRNA (siControl). siRNA-mediated Efp silencing resulted in suppressed spheroid proliferation and altered gene expression profile, featuring downregulation of genes related to cell cycle and inflammation/immune responses. This study provides an insight into alternative endometrial cancer therapeutic strategies targeting Efp.

ORGANISM(S): Homo sapiens

PROVIDER: GSE164724 | GEO | 2024/01/13

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gene expression data from human endometrial cancer cells treated with siRNA targeting Efp

Project description:To examine the role of Efp in endometrial cancer cells, Ishikawa and HEC-1A cells were treated with siRNA targeting Efp (siEfp) or control siRNA (siControl). Microarray analysis showed that Efp knockdown represses NF-κB-signaling pathway-associated genes.

2018-11-20 | GSE118228 | GEO

Gene expression data from endometrial cancer patient-derived cells (EDC-PDCs) treated with Efp siRNA

Project description:Gene expression data from endometrial cancer patient-derived cells (EDC-PDCs) treated with Efp siRNA

| PRJNA691735 | ENA

Gene expression data from human endometrial cancer cells treated with siRNA targeting Efp

Project description:Gene expression data from human endometrial cancer cells treated with siRNA targeting Efp

| PRJNA484902 | ENA

WNK1-dependent transcriptome in decidualized human endometrial stromal cells

Project description:We report the transcriptomic profile of primary human endometrial stromal cells subjected to 48-hour transfection with control non-targeting siRNA or siRNA targeting WNK1 followed by 3-day in vitro decidualization treatment.

2018-08-20 | GSE103329 | GEO

Gene expression profiling of MDA231, BT549, and SUM159PT cells after selumetinib treatment or DUSP4 siRNA knockdown

2013-09-03 | GSE41816 | GEO

Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells

Project description:We report the gene expression profile of primary human endometrial stromal cells treated for 48 hours with control non-targeting, PGR-targeting, or FOXO1-targeting siRNA prior to decidualization stimulus for 72 hours.

2017-01-25 | GSE94036 | GEO

Gene expression data from human ovarian cancer cells treated with siRNAs targeting CPNE8 and BHLHE41

Project description:To examine the role of CPNE8 and BHLHE41 in ovarian cancer cells, RMG1 cells were treated with siRNA targeting CPNE8 (siCPNE8 #A and #B) or control siRNA (siControl), and OVCAR3 cells were treated with siRNA targeting BHLHE41 (siBHLHE41 #A and #B) or control siRNA (siControl). Microarray analysis showed that CPNE8 and BHLHE41 are involved in cellular signaling pathways in ovarian cancer.

2019-08-23 | GSE125542 | GEO

Nuclear RNA-seq of siRNA-mediated METTL3 knockdown

Project description:To identify changes in splicing patterns following METTL3 knockdown, RNA-sequencing was performed on nuclear RNA extracted from cells transfected with METTL3-targeting siRNA or a non-targeting siRNA (siControl).

2019-12-26 | GSE130866 | GEO

Transciptomic analysis of human aortic smooth muscle cells (HASMCs) with BAF60a knockdown

Project description:We used NGS-derived transcriptome profiling (RNA-seq) to compare the transcriptional difference between human aortic smooth muscle cells (HASMCs) transfected with 30nM siRNA targeting BAF60a (siBAF60a) or non-targeting siRNA (siControl)

2020-11-21 | GSE153448 | GEO

Gene expression profiling of MDA231, BT549, and SUM159PT cells after selumetinib treatment or DUSP4 siRNA knockdown

Project description:MDA231, BT549, and SUM159PT basal-like breast cancer cell lines were transfected with non-targeting siRNA (siCONTROL), siRNA targeting DUSP4 (siDUSP4), or siCONTROL + 4 or 24 hr of 1uM selumetinib. Cells were harvested at 96 hr post-siRNA transfection. Data were Log2 RMA normalized. We sought to identify changes in gene expression after MEK inhibition, or after loss of DUSP4 function in breast cancer cell lines.

2013-09-03 | E-GEOD-41816 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data